Call For Abstracts
The 19th Biannual Meeting of the International Neurotoxicology Association Sunday Sept 7 thru Friday Sept 12, 2025 Sommarøy, Norway
The theme of the meeting is “Integration Across Biological and Scientific Domains in Neurotoxicology”. Building on INA meetings of the last decade in Israel (2009), China (2011), the Netherlands (2013), Canada (2015), Brazil (2017), Germany (2019), and the United States (2023), INA-19 will span biological and scientific domains of neurotoxicology to provide attendees with diverse viewpoints and a variety of scientific approaches at the cutting edge of our field.
We currently have 14 accepted or tentatively accepted scientific sessions. There will be two scheduled “open” sessions, as well as the David Ray Symposium. Speakers for these sessions will be selected from submitted abstracts.
We invite you at this time to submit your abstracts for review! Please upload abstracts via the submission system linked below.
The abstract submission deadline for full consideration is February 15, 2025. Extended deadlines may be possible if the meeting venue capacity has not been reached by the Feb 15, 2025 deadline. Once we have reached the capacity of the meeting venue, we will not be able to accept additional abstracts.
Student travel award deadlines will be February 1, 2025. Please submit associated abstracts through the abstract submission portal below. More details on the student awards will be available in early January.
Abstracts are accepted and reviewed on a rolling basis. Decisions are typically made within three weeks of receipt of the abstract.
Please reference the dropdown items below for further information. We look forward to receiving your abstracts!
Abstract Topics
A wide variety of topics are welcome to present at INA-19, including but not limited to:
- Contribution of PBPK modeling to neurotoxicity
- Bridging between in vitro and in vivo to improve interpretation of data
- Epidemiological contributions to understanding chemical effects on human populations
- Mixtures and compound interactions in neurotoxicology
- Human-derived neural stem cells for (developmental) neurotoxicity studies
- Immune-brain interactions in neurotoxicity and disease
- Neural exposome and linking exposome with experimental studies
- Adverse Outcome Pathways in Neurotoxicology
- Genetic and environmental risk factor interaction in neurological disease risk
- Extracellular vesicles in neurotoxicology
- Development and regulatory implementation of new approach methodologies for developmental neurotoxicity testing
- Neurotoxicity of micro- and nanoplastics, chemicals in plastics, leachates
- Emerging single-cell methods in neurotoxicology
- Mechanisms of neural resiliency
Abstract Formatting and Submission Guidelines
Please submit your abstract using the Abstract Submission Portal button at the bottom of the page. In addition to text entry, a PDF version of your abstract should be submitted. You are encouraged to “SAVE” the summary page that is given on the submission webpage once completed.
As a reminder, at INA meetings, you may be the presenting author for either a single talk or poster only. Identifying the presenting author is required when submitting abstracts.
Below is an example abstract:
INA-19 Scientific Organizing Committee
Aaron Bowman, Ph.D., Purdue University, USA (chair)
Pam Lein, Ph.D., UC Davis, USA (INA president)
Oddvar Myhre, Ph.D., Norwegian Inst. of Public Health, Oslo, Norway
Henri Schroeder, Ph.D., University of Lorraine, France, Nancy, France
Tamara Tal, Ph.D., Helmholtz Centre for Environmental Research, Leipzig, Germany
Emma Kasteel, Ph.D., Utrecht University, Utrecht, Netherlands
